Prestige Consumer Healthcare (PBH) Revenue (2010 - 2025)

Prestige Consumer Healthcare has reported Revenue for 16 years, with the latest figure at $283.4 million in Q4 2025.

• On a quarterly basis, Revenue fell 2.37% year-over-year to $283.4 million in Q4 2025; TTM through Dec 2025 was $1.1 billion, a 1.31% decrease from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 1.1% from the prior year.
• Revenue was $283.4 million for Q4 2025 at Prestige Consumer Healthcare, up from $274.1 million in the prior quarter.
• The five-year high for Revenue was $296.5 million in Q1 2025, with the low at $237.8 million in Q1 2021.
• Average Revenue over 5 years is $276.1 million, with a median of $277.0 million recorded in 2022.
• The sharpest annual moves came in 2021 and 2025: Revenue advanced 17.34% in 2021, then retreated 6.59% in 2025.
• Over 5 years, Revenue stood at $274.5 million in 2021, then increased by 0.38% to $275.5 million in 2022, then grew by 2.62% to $282.7 million in 2023, then increased by 2.68% to $290.3 million in 2024, then decreased by 2.37% to $283.4 million in 2025.
• The last three Revenue figures came in at $283.4 million (Q4 2025), $274.1 million (Q3 2025), and $249.5 million (Q2 2025), per Business Quant data.